Two Sigma Advisers’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105M | Buy |
|
|||||
|
2025
Q1 | $63.1M | Buy |
|
|||||
|
2024
Q4 | $47.2M | Buy |
|
|||||
|
2024
Q3 | $53.4M | Buy |
|
|||||
|
2024
Q2 | $61.3M | Buy |
|
|||||
|
2024
Q1 | $45.1M | Buy |
|
|||||
|
2023
Q4 | $39.3M | Buy |
|
|||||
|
2023
Q3 | $27.4M | Buy |
|
|||||
|
2023
Q2 | $14.1M | Sell |
|
|||||
|
2023
Q1 | $12.4M | Sell |
|
|||||
|
2022
Q4 | $24M | Sell |
|
|||||
|
2022
Q3 | $29.1M | Sell |
|
|||||
|
2022
Q2 | $26.1M | Buy |
|
|||||
|
2022
Q1 | $22.7M | Buy |
|
|||||
|
2021
Q4 | $15.1M | Buy |
|
|||||
|
2021
Q3 | $14.5M | Sell |
|
|||||
|
2021
Q2 | $21M | Sell |
|
|||||
|
2021
Q1 | $32.1M | Sell |
|
|||||
|
2020
Q4 | $45.2M | Sell |
|
|||||
|
2020
Q3 | $51.7M | Sell |
|
|||||
|
2020
Q2 | $69.1M | Sell |
|
|||||
|
2020
Q1 | $56.1M | Sell |
|
|||||
|
2019
Q4 | $82.6M | Sell |
|
|||||
|
2019
Q3 | $96.7M | Sell |
|
|||||
|
2019
Q2 | $105M | Buy |
|
|||||
|
2019
Q1 | $65.5M | Buy |
|
|||||
|
2018
Q4 | $32.8M | Buy |
|
|||||
|
2018
Q3 | $15.9M | Buy |
|
|||||
|
2018
Q2 | $1.98M | Sell |
|
|||||
|
2018
Q1 | $7.21M | Buy |
|
|||||
|
2017
Q4 | $7.34M | Buy |
|
|||||
|
2017
Q3 | $1.82M | Buy |
|
|||||
|
2017
Q2 | $1.48M | Buy |
|
|||||
|
2017
Q1 | $286K | Sell |
|
|||||
|
2016
Q4 | $1.19M | Sell |
|
|||||
|
2016
Q3 | $2.61M | Sell |
|
|||||
|
2016
Q2 | $3.86M | Sell |
|
|||||
|
2016
Q1 | $11.2M | Sell |
|
|||||
|
2015
Q4 | $24.5M | Buy |
|
|||||
|
2015
Q3 | $16.5M | Buy |
|
|||||
|
2015
Q2 | $2.52M | Buy |
|
|||||
|
2015
Q1 | $1.49M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $630K | Sell |
|
|||||
|
2013
Q3 | $653K | Buy |
|
|||||
|
2013
Q2 | $290K | Buy |
|